The inhibitory effect of S-nitrosoglutathione on blood-brain barrier disruption and peroxynitrite formation in a rat model of experimental stroke

Journal of Neurochemistry

Volumn 123, Issue SUPPL. 2, 2012, Pages 86-97

  Khan, Mushfiquddin ^a   Dhammu, Tajinder S ^a   Sakakima, Harutoshi ^a   Shunmugavel, Anadakumar ^a   Gilg, Anne G ^a   Singh, Avtar K ^a,b   Singh, Inderjit ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

BBB; endothelial dysfunction; GSNO; ischemia reperfusion; peroxynitrite; S nitrosylation

Indexed keywords

3 NITROTYROSINE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PEROXYNITRITE; PROTEIN ZO1; S NITROSOCYSTEINE; S NITROSOGLUTATHIONE; SYNAPTOTAGMIN I;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN ISCHEMIA; BRAIN LEVEL; CEREBROVASCULAR ACCIDENT; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; MALE; NEUROPROTECTION; NITROSYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; RAT; REPERFUSION INJURY;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN EDEMA; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; E-SELECTIN; ENDOTHELIAL CELLS; EVANS BLUE; FUNCTIONAL LATERALITY; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MATRIX METALLOPROTEINASE 9; NEOPLASM PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS; NITRIC OXIDE; NITRITES; NUCLEOCYTOPLASMIC TRANSPORT PROTEINS; PEROXYNITROUS ACID; PHOSPHOPYRUVATE HYDRATASE; PROTEIN TRANSPORT; PROTEIN-SERINE-THREONINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; S-NITROSOGLUTATHIONE; STATISTICS, NONPARAMETRIC; TIME FACTORS; TYROSINE; ZONULA OCCLUDENS-1 PROTEIN;

EID: 84867556457     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2012.07947.x     Document Type: Conference Paper

References (61)

1. Barone F. C., and, Feuerstein G. Z., (1999) Inflammatory mediators and stroke: new opportunities for novel therapeutics. J. Cereb. Blood Flow Metab. 19, 819-834.
2. Barr T. L., Latour L. L., Lee K. Y., et al,. (2010) Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9. Stroke 41, e123-e128.
3. de Belder A. J., MacAllister R., Radomski M. W., Moncada S., and, Vallance P. J., (1994) Effects of S-nitroso-glutathione in the human forearm circulation: evidence for selective inhibition of platelet activation. Cardiovasc. Res. 28, 691-694.
4. Berti R., Williams A. J., Moffett J. R., Hale S. L., Velarde L. C., Elliott P. J., Yao C., Dave J. R., and, Tortella F. C., (2002) Quantitative real-time RT-PCR analysis of inflammatory gene expression associated with ischemia-reperfusion brain injury. J. Cereb. Blood Flow Metab. 22, 1068-1079.
5. Chen H. Y., Chen T. Y., Lee M. Y., Chen S. T., Hsu Y. S., Kuo Y. L., Chang G. L., Wu T. S., and, Lee E. J., (2006) Melatonin decreases neurovascular oxidative/nitrosative damage and protects against early increases in the blood-brain barrier permeability after transient focal cerebral ischemia in mice. J. Pineal Res. 41, 175-182.
6. Chen H., Yoshioka H., Kim G. S., et al,. (2011) Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid. Redox Signal. 14, 1505-1517.
7. Chou P. C., Shunmugavel A., Sayed H. E., Desouki M. M., Nguyen S. A., Khan M., Singh I., and, Bilgen M., (2011) Preclinical use of longitudinal MRI for screening the efficacy of s-nitrosoglutathione in treating spinal cord injury. J. Magn. Reson. Imaging 33, 1301-1311.
8. Coert B. A., Anderson R. E., and, Meyer F. B., (2003) Is neuroprotective efficacy of nNOS inhibitor 7-NI dependent on ischemic intracellular pH? Am. J. Physiol. Heart Circ. Physiol. 284, H151-H159.
9. Colagiovanni D. B., Borkhataria D., Looker D., Schuler D., Bachmann C., Sagelsdorff P., Honarvar N., and, Rosenthal G. J., (2011) Preclinical 28-day inhalation toxicity assessment of s-nitrosoglutathione in beagle dogs and wistar rats. Int. J. Toxicol. 30, 466-477.
10. Erwin P. A., Lin A. J., Golan D. E., and, Michel T., (2005) Receptor-regulated dynamic S-nitrosylation of endothelial nitric oxide synthase in vascular endothelial cells. J. Biol. Chem. 280, 19888-19894.
11. Fortenberry J. D., Owens M. L., Chen N. X., and, Brown L. A., (2001) S-nitrosoglutathione inhibits TNF-alpha-induced NFkappaB activation in neutrophils. Inflamm. Res. 50, 89-95.
12. Foster M. W., Hess D. T., and, Stamler J. S., (2009) Protein S-nitrosylation in health and disease: a current perspective. Trends Mol. Med. 15, 391-404.
13. Gursoy-Ozdemir Y., Can A., and, Dalkara T., (2004) Reperfusion-induced oxidative/nitrative injury to neurovascular unit after focal cerebral ischemia. Stroke 35, 1449-1453.
14. Heiss C., Lauer T., Dejam A., Kleinbongard P., Hamada S., Rassaf T., Matern S., Feelisch M., and, Kelm M., (2006) Plasma nitroso compounds are decreased in patients with endothelial dysfunction. J. Am. Coll. Cardiol. 47, 573-579.
15. Hoda N., Singh I., Singh A. K., and, Khan M., (2009) Reduction of lipoxidative load by secretory phospholipase A2 inhibition protects against neurovascular injury following experimental stroke in rat. J. Neuroinflammation 6, 21.
16. Horstmann S., Kalb P., Koziol J., Gardner H., and, Wagner S., (2003) Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies. Stroke 34, 2165-2170.
17. Irmak M. K., Fadillioglu E., Sogut S., Erdogan H., Gulec M., Ozer M., Yagmurca M., and, Gozukara M. E., (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem. Funct. 21, 283-289.
18. Jatana M., Giri S., Ansari M. A., Elango C., Singh A. K., Singh I., and, Khan M., (2006) Inhibition of NF-kB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia. J. Neuroinflammation 3, 12.
19. Jiang J., Wang W., Sun Y. J., Hu M., Li F., and, Zhu D. Y., (2007) Neuroprotective effect of curcumin on focal cerebral ischemic rats by preventing blood-brain barrier damage. Eur. J. Pharmacol. 561, 54-62.
20. Ju T. C., Chen S. D., Liu C. C., and, Yang D. I., (2005) Protective effects of S-nitrosoglutathione against amyloid beta-peptide neurotoxicity. Free Radic. Biol. Med. 38, 938-949.
21. Khan M., Sekhon B., Giri S., Jatana M., Gilg A. G., Ayasolla K., Elango C., Singh A. K., and, Singh I., (2005) S-Nitrosoglutathione reduces inflammation and protects brain against focal cerebral ischemia in a rat model of experimental stroke. J. Cereb. Blood Flow Metab. 25, 177-192.
22. Khan M., Jatana M., Elango C., Paintlia A. S., Singh A. K., and, Singh I., (2006) Cerebrovascular protection by various nitric oxide donors in rats after experimental stroke. Nitric Oxide 15, 114-124.
23. Khan M., Elango C., Ansari M. A., Singh I., and, Singh A. K., (2007) Caffeic acid phenethyl ester reduces neurovascular inflammation and protects rat brain following transient focal cerebral ischemia. J. Neurochem. 102, 365-377.
24. Khan M., Im Y. B., Shunmugavel A., Gilg A. G., Dhindsa R. K., Singh A. K., and, Singh I., (2009) Administration of S-nitrosoglutathione after traumatic brain injury protects the neurovascular unit and reduces secondary injury in a rat model of controlled cortical impact. J. Neuroinflammation 6, 32.
25. Khan M., Sakakima H., Dhammu T. S., Shunmugavel A., Im Y. B., Gilg A. G., Singh A. K., and, Singh I., (2011) S-Nitrosoglutathione reduces oxidative injury and promotes mechanisms of neurorepair following traumatic brain injury in rats. J. Neuroinflammation 8, 78.
26. Kluge I., Gutteck-Amsler U., Zollinger M., and, Do K. Q., (1997) S-Nitrosoglutathione in rat cerebellum: identification and quantification by liquid chromatography-mass spectrometry. J. Neurochem. 69, 2599-2607.
27. Kuzkaya N., Weissmann N., Harrison D. G., and, Dikalov S., (2003) Interactions of peroxynitrite, tetrahydrobiopterin, ascorbic acid, and thiols: implications for uncoupling endothelial nitric-oxide synthase. J. Biol. Chem. 278, 22546-22554.
28. Laursen J. B., Somers M., Kurz S., McCann L., Warnholtz A., Freeman B. A., Tarpey M., Fukai T., and, Harrison D. G., (2001) Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. Circulation 103, 1282-1288.
29. Lima B., Lam G. K., Xie L., et al,. (2009) Endogenous S-nitrosothiols protect against myocardial injury. Proc. Natl Acad. Sci. USA 106, 6297-6302.
30. Lo E. H., Dalkara T., and, Moskowitz M. A., (2003) Mechanisms, challenges and opportunities in stroke. Nat. Rev. Neurosci. 4, 399-415.
31. Lundblad C., Grande P. O., and, Bentzer P., (2009) Hemodynamic and histological effects of traumatic brain injury in eNOS-deficient mice. J. Neurotrauma 26, 1953-1962.
32. Marshall H. E., and, Stamler J. S., (2001) Inhibition of NF-kappa B by S-nitrosylation. Biochemistry 40, 1688-1693.
33. Matsuda F., Sakakima H., and, Yoshida Y., (2011) The effects of early exercise on brain damage and recovery after focal cerebral infarction in rats. Acta Physiol. (Oxf) 201, 275-287.
34. Molloy J., Martin J. F., Baskerville P. A., Fraser S. C., and, Markus H. S., (1998) S-nitrosoglutathione reduces the rate of embolization in humans. Circulation 98, 1372-1375.
35. Moskowitz M. A., Lo E. H., and, Iadecola C., (2010) The science of stroke: mechanisms in search of treatments. Neuron 67, 181-198.
36. Pacher P., Beckman J. S., and, Liaudet L., (2007) Nitric oxide and peroxynitrite in health and disease. Physiol. Rev. 87, 315-424.
37. Parathath S. R., Parathath S., and, Tsirka S. E., (2006) Nitric oxide mediates neurodegeneration and breakdown of the blood-brain barrier in tPA-dependent excitotoxic injury in mice. J. Cell Sci. 119, 339-349.
38. Parnham M., and, Sies H., (2000) Ebselen: prospective therapy for cerebral ischaemia. Expert Opin. Investig. Drugs 9, 607-619.
39. Phares T. W., Fabis M. J., Brimer C. M., Kean R. B., and, Hooper D. C., (2007) A peroxynitrite-dependent pathway is responsible for blood-brain barrier permeability changes during a central nervous system inflammatory response: TNF-alpha is neither necessary nor sufficient. J. Immunol. 178, 7334-7343.
40. Prasad R., Giri S., Nath N., Singh I., and, Singh A. K., (2007) GSNO attenuates EAE disease by S-nitrosylation-mediated modulation of endothelial-monocyte interactions. Glia 55, 65-77.
41. Que L. G., Liu L., Yan Y., Whitehead G. S., Gavett S. H., Schwartz D. A., and, Stamler J. S., (2005) Protection from experimental asthma by an endogenous bronchodilator. Science 308, 1618-1621.
42. Radomski M. W., Rees D. D., Dutra A., and, Moncada S., (1992) S-nitroso-glutathione inhibits platelet activation in vitro and in vivo. Br. J. Pharmacol. 107, 745-749.
43. Rashid P. A., Whitehurst A., Lawson N., and, Bath P. M., (2003) Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. J. Stroke Cerebrovasc. Dis. 12, 82-87.
44. Rauhala P., Mohanakumar K. P., Sziraki I., Lin A. M., and, Chiueh C. C., (1996) S-nitrosothiols and nitric oxide, but not sodium nitroprusside, protect nigrostriatal dopamine neurons against iron-induced oxidative stress in vivo. Synapse 23, 58-60.
45. Rauhala P., Lin A. M., and, Chiueh C. C., (1998) Neuroprotection by S-nitrosoglutathione of brain dopamine neurons from oxidative stress. FASEB J. 12, 165-173.
46. Ravi K., Brennan L. A., Levic S., Ross P. A., and, Black S. M., (2004) S-nitrosylation of endothelial nitric oxide synthase is associated with monomerization and decreased enzyme activity. Proc. Natl Acad. Sci. USA 101, 2619-2624.
47. Rosamond W., Flegal K., Furie K., et al,. (2008) Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117, e25-e146.
48. Schonhoff C. M., Matsuoka M., Tummala H., et al,. (2006) S-nitrosothiol depletion in amyotrophic lateral sclerosis. Proc. Natl Acad. Sci. USA 103, 2404-2409.
49. Sharma S. S., Munusamy S., Thiyagarajan M., and, Kaul C. L., (2004) Neuroprotective effect of peroxynitrite decomposition catalyst and poly(adenosine diphosphate-ribose) polymerase inhibitor alone and in combination in rats with focal cerebral ischemia. J. Neurosurg. 101, 669-675.
50. Shlosberg D., Benifla M., Kaufer D., and, Friedman A., (2010) Blood-brain barrier breakdown as a therapeutic target in traumatic brain injury. Nat. Rev. Neurol. 6, 393-403.
51. Singh S. P., Wishnok J. S., Keshive M., Deen W. M., and, Tannenbaum S. R., (1996) The chemistry of the S-nitrosoglutathione/glutathione system. Proc. Natl Acad. Sci. USA 93, 14428-14433.
52. Singh I. N., Sullivan P. G., and, Hall E. D., (2007) Peroxynitrite- mediated oxidative damage to brain mitochondria: Protective effects of peroxynitrite scavengers. J. Neurosci. Res. 85, 2216-2223.
53. Stamler J. S., Toone E. J., Lipton S. A., and, Sucher N. J., (1997) (S)NO signals: translocation, regulation, and a consensus motif. Neuron 18, 691-696.
54. Stanimirovic D. B., Wong J., Shapiro A., and, Durkin J. P., (1997) Increase in surface expression of ICAM-1, VCAM-1 and E-selectin in human cerebromicrovascular endothelial cells subjected to ischemia-like insults. Acta Neurochir. Suppl. 70, 12-16.
55. Strbian D., Durukan A., Pitkonen M., Marinkovic I., Tatlisumak E., Pedrono E., Abo-Ramadan U., and, Tatlisumak T., (2008) The blood-brain barrier is continuously open for several weeks following transient focal cerebral ischemia. Neuroscience 153, 175-181.
56. Thiyagarajan M., Kaul C. L., and, Sharma S. S., (2004) Neuroprotective efficacy and therapeutic time window of peroxynitrite decomposition catalysts in focal cerebral ischemia in rats. Br. J. Pharmacol. 142, 899-911.
57. Weissman D. E., and, Stewart C., (1988) Experimental drug therapy of peritumoral brain edema. J. Neurooncol. 6, 339-342.
58. Yemisci M., Gursoy-Ozdemir Y., Vural A., Can A., Topalkara K., and, Dalkara T., (2009) Pericyte contraction induced by oxidative-nitrative stress impairs capillary reflow despite successful opening of an occluded cerebral artery. Nat. Med. 15, 1031-1037.
59. Yu H., Wang P., An P., and, Yixue X., (2012) Recombinant human angiopoietin-1 ameliorates the expressions of ZO-1, occludin, VE-cadherin, and PKCalpha signaling after focal cerebral ischemia/reperfusion in rats. J. Mol. Neurosci. 46, 236-247.
60. Zanini G. M., Martins Y. C., Cabrales P., Frangos J. A., and, Carvalho L. J., (2012) S-nitrosoglutathione prevents experimental cerebral malaria. J. Neuroimmune Pharmacol. 7, 477-487.
61. Zhang C. L., de la Lande I. S., and, Horowitz J. D., (1995) Effects of glyceryl trinitrate tolerance on vascular responsiveness to constrictor agents in bovine isolated coronary artery. Clin. Exp. Pharmacol. Physiol. 22, 324-329.